Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+1552Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+1670Peak area normalizedfemale normoglycemic no neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+3264Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+3501Peak area normalizedmale diabetic Neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+3789Peak area normalizedmale pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+4269Peak area normalizedmale pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+5146Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+5241Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+6192Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+6223Peak area normalizedfemale normoglycemic Neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+7126Peak area normalizedfemale diabetic no neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+Peak area normalizedfemale diabetic Neuropathy
Reversed phase POSITIVE ION MODEBILIVERDIN (M+H)+Peak area normalizedmale diabetic no neuropathy

Return to search page
  logo